NICE guidance emphasises that GLP-1 medications for weight management (Wegovy and Saxenda) should be used alongside lifestyle modifications, including dietary changes and increased physical activity
NCT04847557) seeks to evaluate the effect of tirzepatide (is a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors) over 52 weeks in 700 patients with heart failure with preserved ejection fraction (HFpEF) and obesity
Convenient, discreet use compared to injections
Lets be paying attention to these little detours and these interesting opportunities, because youre right, sometimes a really well-placed yes turns into a completely different road
Introduction In recent years, GLP-1 receptor agonists , such as Ozempic, have made waves for their powerful ability to aid in weight loss
Alcohol use compounds this